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Endothelial Dysfunction Augments Myogenic
Arteriolar Constriction in Hypertension
An Huang, Dong Sun, Akos Koller
To elucidate the underlying reason or reasons for the increased peripheral resistance in hypertension, we
investigated the pressure-diameter relation —the myogenic response—of isolated, cannulated arterioles
(approximately 50 /im) of cremaster muscle of 12-week-old Wistar-Kyoto (WKY) rats, spontaneously
hypertensive rats (SHR), and normal Wistar (NW) rats. All arterioles constricted in response to step
increases in perfusion pressure from 20 to 160 mm Hg. This constriction was, however, significantly
enhanced from 60 to 160 mm Hg in arterioles of SHR compared with NW or WKY rats. For example, at
80 and 140 mm Hg, respectively, the normalized diameter (expressed as a percentage of the corresponding
passive diameter of arterioles of SHR) was 11.8% and 27.6% (P<.05) less compared with those of WKY
rats. Endothelium removal eliminated the enhanced pressure-induced tone in SHR. Similarly, indometh-
acin (10~s mol/L, sufficient to block prostaglandin synthesis) or SQ 29,548 (10"' mol/L), a thromboxane
Aj-prostaglandin H2 receptor blocker that inhibited vasoconstriction to the thromboxane agonist U46619,
attenuated the enhanced pressure-diameter curve and reversed the blunted dilation to arachidonic acid
in SHR. In contrast, the thromboxane A2 synthesis inhibitor CGS 13,080 (5x 10"' mol/L) did not affect the
increased pressure-induced tone or the reduced dilation to arachidonic acid in SHR. Thus, the present
findings suggest that in early hypertension pressure-induced arteriolar constriction is increased. This
seems to be due to an enhanced production of endothelium-derived constrictor factors, primarily
prostaglandin H2. (Hypertension. 1993;22:913-921.)
KEY WORDS • myogenic response • arachidonic acid • prostaglandins • acetylcholine •
nitroprusside • indomethacin • receptors, thromboxane
In vivo studies of the microcirculation of skeletalmuscle in hypertension have demonstrated a vari-ety of changes in the vascular wall and network
architecture, which are believed to be a consequence of
the increased intravascular pressure.'-* These structural
changes are thought to contribute to the maintenance of
increased peripheral vascular resistance.5'6 Although in
previous studies9-12 the changes in the vasoactive func-
tion of large arteries in various forms of hypertension
have been amply demonstrated, such investigations are
sparse in microvessels.1314
One of the primary local mechanisms that regulate
arteriolar diameter is the myogenic response.1517 Be-
cause this mechanism is activated by the transmural
pressure, it is logical to assume that it is altered by the
presence of an increased pressure in hypertension.
Indeed, an augmented vasoconstrictor response to
changes in intravascular pressure is characteristic of
patients with essential hypertension.18 Although in most
microvascular beds the myogenic response is intrinsic to
vascular smooth muscle,1719-20-21 in some vessels the
endothelium seems to have an obligatory role or con-
tributes significantly to it.22-23 Based on these studies we
hypothesized (1) that the chronic presence of high
intravascular pressure in hypertension may alter pres-
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sure-sensitive vascular mechanisms, resulting in an en-
hanced arteriolar tone and (2) that endothelial factors
contribute to the enhanced pressure-induced constric-
tion of arterioles.
To test these ideas we investigated the changes in
arteriolar diameter as a function of intravascular pres-
sure in static flow conditions in isolated cremasteric
arterioles of normotensive and spontaneously hyperten-
sive rats (SHR). In addition, the possible role of the
endothelium of arterioles in the development and/or
modulation of myogenic constriction was assessed by
removal of the endothelium and the use of pharmaco-
logic agents affecting the cyclooxygenase pathway.
Methods
Experiments were conducted on isolated second-
order arterioles (approximately 50 /xm) of cremaster
muscle of 12-week-old male normal Wistar (NW) rats,
Wistar-Kyoto (WKY) rats, and SHR. The procedures
and protocols of study were in accordance with our
institutional guidelines. Systolic arterial blood pressure
was measured by the tail-cuff method. Rats were anes-
thetized with intraperitoneal injections of sodium pen-
tobarbital (Nembutal sodium, 50 mg/kg). The isolation
procedure of cremasteric arterioles has been described
previously.21 Briefly, the cremaster muscle of rats was
exposed by a median incision of the scrotal sac, cleared
of adhering fascia, and separated from the scrotal sac.
The muscle then was cut out and placed on a Petri dish
containing cold (0° to 4°C) salt solution (pH 7.4) com-
posed of (mmol/L) NaCl, 145; KC1, 5.0; CaCl2, 2.0;
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MgSO4, 1.0; NaH2PO4, 1.0; dextrose, 5.0; pyruvate, 2.0;
EDTA, 0.02; and 3-(N-morpholino)propanesulfonic
acid, 3.0. The muscle was pinned to the silicone bottom
of the dish and allowed to equilibrate for approximately
15 minutes. After the muscle had been dissected, rats
were euthanized by an overdose of pentobarbital
sodium.
With the use of microsurgery instruments and an
operating microscope (Olympus), four segments, 1 to 2
mm in length, of second-order arterioles branching off
from the main (first-order) arteriole supplying the mus-
cle were isolated sequentially from both cremaster
muscles then transferred to the vessel chamber. The
chamber contained four pairs of glass micropipettes
filled with physiological salt solution (PSS) (see below)
at room temperature.
The four proximal (inflow) micropipettes were con-
nected to four silicone rubber tubes linked to a pres-
sure-servo syringe system (Living Systems Inc, Burling-
ton, Vt). All distal (outflow) pipettes were equipped
with a three-way stopcock. PSS used for suffusion and
perfusion of the vessels contained (mmol/L) NaCl,
110.0; KC1, 5.0; CaCl2, 2.5; MgSO4, 1.0; dextrose, 10.0;
NaHCO3, 24.0; and EDTA, 0.02 and was equilibrated
with a gas mixture of 21% O2 and 5% CO2 balanced
with N2, at pH 7.4 (33°C). From a reservoir, the vessel
chamber (20 mL) was continuously supplied with PSS at
a rate of 40 mL/min.
After all four vessels had been mounted on their
proximal pipettes and secured with sutures, perfusion
pressure was raised to 20 mm Hg to clear clotted blood
from the lumens, then the other end of the vessels was
mounted on the distal pipettes. To flush the vessels and
cannulas, the system was perfused for several minutes,
then the outflow cannulas were closed, and the perfu-
sion pressure was slowly (approximately 1 minute)
increased to 80 mm Hg. At this time, the pressure-servo
system was placed in the manual mode (ie, no automatic
maintenance of perfusion pressure) to ascertain that
there were no leaks in the system. If no leaks were
detected (ie, perfusion pressure remained constant),
the pressure-servo system was set in the automatic
mode. The temperature was set to 33°C (YSI tempera-
ture controller), and the vessels were allowed to equil-
ibrate for approximately 1 hour.
Experimental Procedure
In all protocols, the changes in diameter of arterioles
in response to increases in perfusion pressure under
no-flow conditions were measured with a reticle gener-
ator and recorded with an X-Y recorder. Only those
vessels that developed spontaneous tone to pressure (80
mm Hg) were used, as there was no vasoactive agent
added to the PSS. After the equilibration period, per-
fusion pressure was decreased to 20 mm Hg and then
increased in steps of 20 mm Hg to 160 mm Hg. Each
pressure step was maintained for 5 to 10 minutes to
allow the vessels to reach a stable condition before the
diameter of the arterioles was measured. After the
pressure-diameter relation was obtained, the pressure
was lowered to 80 mm Hg, then after approximately 20
minutes responses of arterioles to vasoactive agents
were tested.
In the first protocol after control responses, the
endothelium of the arterioles was removed by perfusion
of the vessels with air, as previously described in de-
tail.21 The arteriole was untied from the proximal pi-
pette, and air (approximately 1 mL) was injected
through the distal pipette into the lumen for 1 minute.
Then the arteriole was remounted to the proximal
pipette. This procedure was repeated in each vessel.
The arterioles were then perfused with PSS for 20
minutes at a pressure of 20 mm Hg to clear the debris.
The outflow stopcock was then closed and perfusion
pressure raised to 80 mm Hg for 30 minutes for retrieval
of a stable tone. At this pressure the efficacy of endo-
thelial denudation was ascertained by testing the arte-
riolar responses to acetylcholine (5xl0~8 mol/L) and
sodium nitroprusside (10~7 mol/L), endothelium-depen-
dent and -independent vasodilators,24'25 respectively,
before and after the administration of the air bolus.
After removal of the endothelium, changes in diameter
in response to step increases in perfusion pressure were
reassessed.
In the second series of experiments, after control
pressure-diameter curves were obtained, the vessels
were subjected to indomethacin (10~5 mol/L), an inhib-
itor of prostaglandin synthesis, instead of endothelial
denudation. Then changes in diameter in response to
step increases in perfusion pressure were reassessed.
Arteriolar responses to arachidonic acid (10~5 mol/L)
and prostaglandin E2 (PGE2, 5xl0"8 mol/L) were ob-
tained before and after the vessels were exposed to
indomethacin.
In the third group of experiments, the pressure-
diameter relation was investigated in control conditions
and in the presence of SQ 29,548 (10~6 mol/L), known
to be a thromboxane A2 (TXA2)-prostaglandin H2
(PGH2) receptor antagonist.26 The efficacy of this an-
tagonist was tested by U46619 (10~8 mol/L), a TXA2-
PGH2 receptor agonist. In the fourth group of experi-
ments the effect of CGS 13,080 (5xl0"6 mol/L), an
inhibitor of TXA2 synthetase,27 on the pressure-induced
changes in diameter was assessed. In both the third and
fourth groups of experiments, dilation in response to
arachidonic acid was also tested.
All drugs were added to the reservoir connected to
the vessel chamber, and final concentrations are given.
Responses to vasoactive agents were tested at 80
mm Hg perfusion pressure. At the conclusion of each
experiment, the suffusion solution was changed to a
Ca2+-free PSS that contained sodium nitroprusside
(10~4 mol/L) and EGTA (1.0 mmol/L). The vessels were
incubated for 10 minutes, then the step increases in
pressure were repeated, and the passive diameter of
arterioles at each pressure step was obtained.
All salts and chemicals were obtained from Sigma
Chemical Co, St Louis, Mo, or Aldrich Chemical Co,
Milwaukee, Wis, and were prepared on the day of the
experiment. Changes in diameter in response to vaso-
active agents or pressure were normalized to the corre-
sponding passive diameter and expressed as percent
changes. Results are presented as mean±SEM. N and n
refer to the number of rats and vessels, respectively.
Statistical analyses were done by analysis of variance
(random and fixed models were used for data of myo-
genic responses within groups and between groups,
respectively), followed by Tukey's post hoc test, regres-
sion analysis, and Student's t test (paired and grouped /
tests) were used for data of drug responses within and
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between groups, respectively), as appropriate. A value
of P<.05 was considered significant.
Results
The systolic blood pressures of NW and WKY rats
and SHR were 103.9±3.0 (n=6), 119.1+7.8 (n=6), and
194.9±3.0 (n=7) mm Hg, respectively, showing a signif-
icant increase in blood pressure in SHR compared with
NW and WKY rats. There was no significant difference
between the systolic pressure of NW and WKY rats.
In the first series of experiments, the diameter of NW,
WKY, and SHR arterioles as a function of perfusion
pressure was obtained in the presence and absence of
endothelium. To assess the magnitude of the pressure-
induced changes in diameter, we also obtained after the
conclusion of experiments the passive pressure-diame-
ter relation of arterioles in Ca2+-free solution in all
three rat strains (see "Methods").
Fig 1 (top) demonstrates the changes in the normal-
ized diameter of NW, WKY, and SHR arterioles in
response to step increases in perfusion pressure. The
changes in diameter at each pressure step were normal-
ized to the corresponding passive diameter. From 40
mm Hg perfusion pressure, the slopes of the pressure-
diameter curve of SHR arterioles started to deviate
significantly (P<.05) from those of NW and WKY
arterioles (Fig 1, top panel inset), indicating that SHR
arterioles have an enhanced constriction in response to
step increases in perfusion pressure compared with
arterioles of normotensive rats. Also, in the range of 80
to 160 mm Hg pressure, the diameter of SHR arterioles
was significantly less than those of normotensive rats.
This finding was further analyzed in the middle panel of
Fig 1. We found that the differences between the
normalized diameter of normotensive and hypertensive
rats increased as a function of intravascular pressure, as
indicated by the significant correlation of these two
parameters. The bottom panel of Fig 1 shows that
although the diameters of arterioles of the various rat
strains were the same at 20 mm Hg pressure, the
pressure-passive diameter relations of SHR and WKY
arterioles were significantly different from that of NW
arterioles.
To assess the role of endothelium in the enhanced
constriction to pressure, we removed the endothelium
of arterioles. As in previous studies20-21 we found that
infusion of air resulted in loss of the endothelium, as
indicated by the absence of dilation to acetylcholine
while dilation to sodium nitroprusside remained intact
(Table 1). Fig 2 (middle) shows that after endothelium
removal, the pressure-diameter curve of WKY rats
shifted downward; that is, the constriction of the arte-
rioles in response to pressure was significantly en-
hanced. In contrast, in SHR (Fig 2, bottom), after
removal of the endothelium the pressure-diameter
curve of arterioles shifted significantly upward; that is,
the constriction of vessels to pressure was significantly
reduced.
Next we investigated the endothelial mechanism or
mechanisms responsible for the pressure-induced en-
hanced constriction of SHR arterioles. Dilator re-
sponses of arterioles to arachidonic acid were signifi-
cantly blunted in SHR compared with NW or WKY
rats, and dilation to PGE2 was also reduced in both
WKY rats and SHR compared with NW rats (Table 2).
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FIG 1. Top: Line graph shows comparison of pressure-
induced changes in normalized diameter of endothelium-
irrtact (control) arterioles of normal Wistar (NW) (N=25 rats,
n=44 vessels), Wistar-Kyoto (WKY) (N=24, n=46), and
spontaneously hypertensive (SH) (N=28, n=55) rats.
Changes in diameter were normalized to passive diameter
at the corresponding perfusion pressures. Analysis of vari-
ance indicates that the slope of pressure-diameter curves of
arterioles was significantly different (P<.05) between 40
and 80 mm Hg pressure, as also illustrated by the linear
regression lines in the inset Inset: Diameters were normal-
ized to 40 mm Hg pressure. Dashed, dotted, and solid lines
represent data of NW, WKY, and SH rats, respectively. NW:
y=-0.91x+134.8, r=.99; WKY: y=-0.89x+132.2, r=.95;
SH: y= -1.10x+141.0, r=.98. Middle: Line graph shows
differences in normalized arterioiar diameter as a function of
perfusion pressure in NW and SH and WKY and SH rats,
respectively. Regression lines y=0.085x-35.8 and
y=0.13x-5.67 have significant r values of .93 and .96,
respectively (P<.01). Bottom: Line graph shows compari-
son of pressure-passive diameter curves of arterioles of
various rat strains. *Significant difference between NW and
WKY or SHR rats. Data are mean±SEM.
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TABLE 1. Effect of Endotriellum Removal on Arteriolar
Responses to Acetyichollne and Sodium Nitroprusslde
AcetytchoUne Sodium NHropnisslde
Rat Strain Control - E Control - E
NW
(N=5, n=9) 33.3±3.6 -1.3±0.4* 22.4±2.9 22.7±2.7
WKY
(N°6, n=8) 30.3±4.2 -1.0±0.7* 17.2±1.1t 16.2±1.0t
SHR
(N=6, n=10) 30.3+2.54 -0.8±0.3* 15.6±1.3t 16.2±1.4t
- E Indicates endothelium removed; NW, normal Wistar rats;
WKY, Wlstar-Kyoto rats; and SHR, spontaneously hypertensive
rats. Data are mean±SEM of percent changes In arteriolar
diameter in response to 5x10~8 mol/L acetyichollne and 10"7
mol/L sodium nltroprusside before (control) and after removal of
endothelium. N Is number of rats; n is number of vessels.
*Slgnlficant difference (P<.05) from control.
tSigntficant difference (P<.05) of arteriolar responses of WKY
rats and SHR from those of NW rats in the same conditions.
The efficacy of the inhibition of cyclooxygenase by
indomethacin is indicated by the elimination of the
dilation to arachidonic acid in all three rat strains.
Indomethacin restored the dilation to PGE2 in SHR
comparable to the responses in NW arterioles (Table 2).
In normotensive rats indomethacin slightly enhanced
pressure-induced arteriolar tone, but except at 160
mm Hg pressure in NW arterioles, there were no signif-
icant differences between the pressure-diameter curves
of NW and WKY arterioles before or after inhibition of
cyclooxygenase (Fig 3, top and middle). In contrast, in
SHR arterioles, indomethacin significantly reduced the
arteriolar constriction in response to step increases in
perfusion pressure (Fig 3, bottom).
In other experiments the effect of SQ 29,548, a
TXA2-PGH2 receptor blocker, on the pressure-induced
behavior of arterioles was examined. SQ 29,548 elimi-
nated the arteriolar constriction to U46619, known to be
a specific agonist of this receptor in all three rat strains,
and normalized the diminished dilation to arachidonic
acid in SHR arterioles (Table 3). Also, although SQ
29,548 did not affect pressure-diameter relations of NW
and WKY arterioles, it significantly reduced the pres-
sure-induced arteriolar constriction of SHR (Fig 4).
To further elucidate the nature of the endothelial
mediator involved in the enhanced arteriolar constric-
tion in SHR, we investigated the effects of CGS 13,080,
a TXA2 synthesis blocker, on the pressure-diameter
curve of arterioles of various rat strains. Table 4 shows
that this compound affected neither the constriction to
U46619 nor the blunted dilation to arachidonic acid in
SHR. We also found that although CGS 13,080 elicited
a reduction in arteriolar diameter at low intravascular
pressures in all rat strains (most likely a nonspecific
effect), it did not affect the pressure-diameter curve of
arterioles (Fig 5).
In all groups of experiments we found that dilation to
arachidonic acid was blunted somewhat in WKY com-
pared with NW arterioles, but this difference reached
significance only when all data were combined. In this
case, dilation to arachidonic acid of NW arterioles was
significantly greater (28.9±1.9%; N=20, n=30) than
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FIG 2. Une graphs show arteriolar diameter as a func-
tion of perfusion pressure of normal Wistar (NW) (N=5
rats, n=9 vessels), Wistar-Kyoto (WKY) (N=6, n=10),
and spontaneously hypertensive (SH) (N=6, n=10) rats
before and after removal of endothelium. Open circles
represent diameter of arterioles with endothelium (con-
trol); filled circles represent diameter of arterioles without
endothelium (-EC); open triangles represent passive
diameter (PD) of arterioles in Ca2+-free solution (see
"Methods"). Data are mean±SEM. *Statistically signifi-
cant differences (P<.05) between arteriolar diameters
with (control) and without (-EC) endothelium at corre-
sponding perfusion pressures.
that of WKY arterioles (22.5±1.5%; N=18, n=36)
(P<.05).
Discussion
The salient findings of this study are that in young
SHR the diameter of arterioles at each pressure step is
significantly less than that of normotensive rats. The
enhanced constriction of arterioles in hypertensive rats
correlates significantly with increases in perfusion pres-
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TABLE 2. Effect of Indomethadn on Arteriolar Responses
to Arachldonic Acid and Prostaglandin Ej
Rat Strain
NW
(N=7, n=11)
WKY
(N=6, n=16)
SHR
(N=8, n=21)
Arachldonic Add
Control
30.5±2.4
25.4±2.5
13.3±3.2f+
Indo
0.8+0.3*
0.1+0.3*
0.4+0.3*
Prostaglandin E2
Control
27.2±2.1
19.2±1.6t
18.8±1.8t
Indo
30.8±0.3
21.1±1.4t
25.7±2.0*t
Indo indicates indomethacin; NW, normal Wistar rats; WKY,
Wistar-Kyoto rats; and SHR, spontaneously hypertensive rats.
Data are mean±SEM of percent changes in arteriolar diameter in
response to 10~5 mol/L arachldonic acid and 5x10" ' mol/L
prostaglandin E2 in control and after treatment with 10~5 mol/L
Indomethacin. N is number of rats; n is number of vessels.
*Significant difference (P<.05) from control.
tSignificant difference (P<.05) from responses of NW rats in
the same conditions.
•Significant difference (P<.05) between WKY rats and SHR in
the same conditions.
sure. Moreover, the enhanced constriction of arterioles
is primarily due to the continuous release of an endo-
thelium-derived constrictor prostanoid.
Previous investigation of the microcirculation of hy-
pertensive animals revealed structural changes in the
vascular wall as well as architectural changes in the
arteriolar network.'•"•28 These changes were used to
explain the enhanced peripheral resistance that accom-
panies hypertension.56 The question our study ad-
dressed was whether alterations in the function of
arteriolar endothelium and/or smooth muscle in the
development of pressure-induced tone could be ob-
served in isolated arterioles of young genetically hyper-
tensive rats and if so, whether this could be related to
the elevated intravascular pressure. Arterioles of rat
cremaster muscle were chosen for the present study
because many previous studies investigating the effects
of hypertension on the microcirculation have been
conducted in this vascular bed.1"4 Also, in this prepara-
tion micropressure measurements in vivo showed that
intravascular pressure was elevated in second-order
arterioles (approximately 50 fim) of SHR compared
with normotensive rats,29-30 the same vessels we used in
the present study.
To avoid the interference of other local mechanisms,
besides the pressure-sensitive mechanism, that regulate
arteriolar diameter, we investigated the presence of and
changes in the myogenic mechanism in isolated cannu-
lated arterioles under no-flow conditions. We used
relatively young 12-week-old animals, an age at which
SHR already have a significantly elevated blood pres-
sure compared with NW or WKY rats.
In response to increases in perfusion pressure, arte-
rioles of hypertensive rats exhibited an enhanced con-
striction compared with normotensive rats. The increase
in tone was eliminated by removal of the endothelium
(Fig 2, bottom), indicating that arteriolar endothelium
of hypertensive rats produces a factor or factors that
constrict arteriolar smooth muscle and are responsible
for the enhanced constriction. Furthermore, the posi-
tive correlation between the increase in pressure and
the additional constriction (Fig 1, middle) suggests that
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FIG 3. Line graphs show effect of indomethacin (INDO,
10~5 mol/L) on pressure-diameter relations in arterioles of
normal Wistar (NW) (N=7 rats, n=12 vessels), Wistar-
Kyoto (WKY) (N=6, n=16), and spontaneously hyperten-
sive (SH) (N=8, n=21) rats. Data are mean±SEM. •Sta-
tistically significant differences (P<.05) between arteriolar
diameters in control condition and presence of indometh-
acin. PD, passive diameter.
the synthesis of the endothelial factor or factors is
coupled to the increases in pressure. Release of a
constrictor factor from the endothelium in response to
pressure23 was reported previously in cerebral arteries
of normotensive rats but as yet not in other vascular
beds.
Removal of the endothelium moderated the pressure-
induced constriction of WKY but not NW arterioles,
indicating a continuous synthesis and release of an
endothelium-derived dilator factor or factors that atten-
uate the myogenic tone of WKY arterioles. Our previ-
ous findings also demonstrated a modulatory role of
endothelium in the myogenic tone of gracilis muscle
arterioles but not of mesenteric arterioles in normoten-
sive rats.17-20 In the present experiments in arterioles
with intact endothelium, the pressure-induced constric-
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TABLE 3. Effects of SQ 29,548 on Arterlolar Responses to VasoactWe Agents
Rat Strain
NW(N=8, n = 11)
WKY (N=7, n=12)
SHR(N=8, n=13)
U46619
Control
-13.4±1.2
-13.8±0.8
-14.8±0.6
SQ 29,548
-0.9±0.2*
-1.4±0.4*
-0.5±0.2*
Arachldonlc Acid
Control
26.7±2.4
20.7±2.2
9.0±1.4n
SQ 29,548
29.2±4.5
25.2±2.3
30.1 ±2.6*
NW indicates normal Wistar rats; WKY, Wlstar-Kyoto rats; and SHR, spontaneously hypertensive
rats. Data are mean±SEM of percent changes In diameter of arterioles in response to 10~8 mol/L
U46619 and 1 f r 5 mol/L arachidonic add before (control) and after 1rr0 mol/L SQ 29,548. N is number
of rats; n is number of vessels.
*Significant difference (P<.05) in responses between control and in the presence of SQ 29,548.
tSignificant difference (P<.05) between NW rats and SHR in the same conditions.
^Significant difference (P<.05) between WKY rats and SHR in the same conditions.
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FIG 4. Line graphs show effect of SQ 29,548 (1CT6
mol/L) on pressure-diameter relations in arterioles of
normal Wistar (NW) (N=8 rats, n=14 vessels), Wistar-
Kyoto (WKY) (N=7, n=12), and spontaneously hyperten-
sive (SH) (N=8, n=13) rats. Data are mean±SEM. *Sig-
nificant differences in arteriolar diameters in control and
presence of SQ 29,548. PD, passive diameter.
tion of hypertensive arterioles was significantly en-
hanced compared with that of normotensive vessels, as
indicated by the significantly steeper slopes of the
pressure-diameter curves of SHR arterioles between 40
and 80 mm Hg perfusion pressure compared with those
of NW and WKY arterioles (Fig 1).
All these findings indicate that endothelium has an
important modulatory role in the generation of the
spontaneous tone of hypertensive arterioles and that in
the operational pressure range for vessels of this size29
the responsiveness of arterioles to pressure is enhanced.
Previous studies demonstrated alterations in the
function of arterial endothelium of prehypertensive
SHR.31 Because in the present experiments the blood
pressure of SHR was already elevated, one cannot
conclude with any certainty whether the observed
change in the function of endothelium has an etiologic
role in or is the result of the elevation of blood pressure.
It is likely, however, that the early changes in the
vasoactive function of arteriolar endothelium precede
the structural changes of the arteriolar wall in this form
of hypertension. Based on the measurement of passive
diameters, the distensibilites of WKY and SHR arteri-
oles do not differ significantly, but they both differ from
NW arterioles (Fig 1, bottom). These findings corre-
spond to in vivo data obtained in cremaster1-2-29-30 and
spinotrapezius32 muscle of WKY rats and SHR, tissues
in which no significant differences in average basal
diameter of arterioles were found. Our findings also
suggest that the changes in distensibility of SHR arte-
rioles are not necessarily due to pressure but are
perhaps genetically determined.
In previous in vivo studies, measurement of blood
pressure in arterioles of skeletal (cremaster) muscle
revealed that, although in the larger arterioles (approx-
imately 80 to 150 Jim) of SHR the intravascular pres-
sures were substantially elevated compared with those
of WKY rats, this difference was diminished by ap-
proaching the entry region of capillaries.2930 These and
our studies are consistent with the suggestion that in
hypertension the arterioles located in the proximal part
of the microcirculation are the ones that exhibit an
enhanced constriction, maintaining normal arteriolar
pressure in distal parts of the network. This would help
to preserve the function and structure of smaller arte-
rioles8 and by regulating capillary hydrostatic pressure
would also assist in the maintenance of fluid balance in
the capillary and postcapillary regions.
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TABLE 4. Effects of CGS 13,080 on Arterlolar Responses to Vasoactlve Agents
Rat Strain
NW (N=5, n=9)
WKY (N=5, n=8)
SHR(N=6, n=11)
Control
-17.4±1.3
-16.2±1.3
-14.1 ±0.6
U46619
COS 13,080
-13.3±0.7
-15.9±1.1
-10.8±0.7
Arachldonlc
Control
29.4±4.9
19.3±3.2
9.3±1.5*t
Acid
CGS 13,080
25.5±3.0
17.8±3.8
7.9±1.8*t
NW indicates normal Wistar rats; WKY, Wistar-Kyoto rats; and SHR, spontaneously hypertensive
rats. Data are mean±SEM of percent changes in diameter in response to 10~8 mol/L U46619 and 10~5
mol/L arachidonk: acid before (control) and after administration of 5x10" ' mol/L CGS 13,080. N is
number of rats; n Is number of vessels.
•Significant difference (P<.05) between NW rats and SHR.
tSignificant difference (P<.05) between NW rats and SHR in the same conditions.
Studies of the responses to vasoactive agents of ring
preparations of rat aorta10 and mesenteric arteries11-31
demonstrated that endothelial function is altered in
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FIG 5. Une graphs show effect of CGS 13,080 (5x10"B
mol/L) on pressure-diameter relations of arterioles of nor-
mal Wistar (NW) (N=5 rats, n=9 vessels), Wistar-Kyoto
(WKY) (N=5, n=8), and spontaneously hypertensive (SH)
(N=6, n=11) rats. Data are mean±SEM. *Significant
differences (P<.05) in arteriolar diameters in control and
presence of CGS 13,080. PD, passive diameter.
hypertensive animals. In these vessels responses to an
endothelium-dependent dilator agent, acetylcholine,
were reduced or reversed to constriction, whereas those
to endothelium-independent dilator agents were re-
tained. It was also shown that this change in the
function of endothelium in hypertension might be
linked to changes in arachidonic acid metabolism33 or
production of superoxide anions.31 Although these stud-
ies revealed changes in vascular function in hyperten-
sion, the vessels were not cannulated and pressurized;
rather, they were preconstricted with vasoactive agents,
and therefore, the role of the observed vascular changes
in pressure-induced tone development could not be
elucidated. Also, because the contribution of conduit
vessels to peripheral resistance is negligible, the rele-
vance of the above findings with regard to the patho-
genesis of hypertension is equivocal.
Previous studies in Dahl hypertensive rats also found
a decrease in the basal release of endothelium-derived
relaxing factor13 but no appreciable change in the
dilation of arterioles of spinotrapezius muscle to acetyl-
choline. In the present study we also did not find a
diminished response to acetylcholine (Table 1), indicat-
ing that nitric oxide synthesis is preserved in the cre-
masteric arterioles of young SHR. Interestingly, how-
ever, dilations to sodium nitroprusside were reduced in
SHR, a finding for which at present we have no expla-
nation.
Currently, little is known concerning the changes in
the myogenic response or the function of the endothe-
lium of arterioles of skeletal muscle in hypertension.
Interestingly, whereas in renal arteries of SHR myo-
genic tone was enhanced,34 in Dahl (salt-sensitive)
hypertensive rats renal microvessels showed impaired
myogenic responses,33 indicating that different mecha-
nisms are present in different forms of hypertension.
That the endothelium augments the pressure-induced
behavior of skeletal muscle arterioles has not been
demonstrated previously. It is also important to point
out that our findings were obtained during no-flow
conditions, as it was shown previously that in the
presence of (blood) flow the release of endothelial
factors affects arteriolar tone.21-3637 In SHR, inhibition
of prostaglandin synthesis at the level of cyclooxygenase
had a significant moderating effect on the pressure-
diameter relation of arterioles similar to that of removal
of the endothelium, suggesting the synthesis by endo-
thelium of a constrictor factor that is prostanoid in
nature.
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Previous studies showed that in response to the
administration of arachidonic acid the endothelium of
cremasteric microvessels of normotensive rats produces
primarily prostaglandin I2 (PGI2) and PGE2.38 It is likely
that in SHR the reduction in dilation to arachidonic
acid is due to an enhanced production of a constrictor
prostanoid associated with and perhaps the result of a
diminished synthesis of dilator prostaglandins, such as
PGI2 and PGE2. This idea is also supported by previous
studies that showed reduced hypotensive responses to
arachidonic acid in SHR.39 In addition, the sensitivity of
vascular smooth muscle to prostaglandins seems to be
decreased in both SHR and WKY rats. It is noteworthy
that the responses of WKY arterioles to arachidonic
acid and PGE^ but not to pressure were blunted com-
pared with NW arterioles. Also, it seems that in WKY
rats there may be an enhanced synthesis of endotheli-
um-derived dilator factors that counteracts the increase
in arteriolar tone to pressure (Fig 2, middle). In addi-
tion, WKY arterioles, unlike NW and SHR arterioles,
were not able to maintain a constriction at higher
intravascular pressures (Figs 1 and 2). All of these
findings led us to speculate that there may be some
alterations (perhaps genetic) in the structure and func-
tion in WKY arterioles that are quite like those in SHR
arterioles, but because they are not exposed to high
intravascular pressures in vivo, their pressure-induced
responses are more like those of NW arterioles.
With the use of a TXArPGH2 receptor antagonist
and a thromboxane synthesis blocker, our study re-
vealed an alteration in the synthesis of prostaglandins
in the endothelium of skeletal muscle arterioles of
SHR. These experiments demonstrated that the
TXA2-PGH2 receptor antagonist SQ 29,548 restored
the normal pressure-diameter curve and the dilation
to arachidonic acid. Interestingly, blockade of TXA2
synthesis elicited a constriction at lower pressures in
all rat strains, most likely because of a nonspecific
effect of the inhibitor used. Nevertheless, CGS 13,080
failed to reverse the enhancement of the pressure-
diameter curve and also failed to normalize dilation to
arachidonic acid, suggesting that an overproduction of
PGH2 rather than TXA2 is responsible for the en-
hanced myogenic tone of SHR arterioles. This conclu-
sion is supported by previous studies which showed
that activation of TXA2-PGH2 receptors is important
in the altered responses of conduit arteries40-42 and
pial arterioles43 of SHR to endothelium-dependent
dilator agents, indicating that in hypertension changes
in arachidonic acid metabolism are not unique to the
skeletal muscle microcirculation.
That the constriction to a TXA2 receptor agonist
(U46619) was similar in arterioles of all three rat strains
indicates no increase in the sensitivity or number of
these receptors in SHR. The present findings support
the hypothesis that in arterioles of genetically hyperten-
sive rats endothelial metabolism of arachidonic acid is
shifted from dilator to constrictor prostanoids, ie, that
there is an enhanced synthesis of PGH2 at the expense
of PGE^/PG^. Thus, one may suspect a causal relation
between elevated intravascular pressure and the altered
prostaglandin synthesis in arteriolar endothelium. In
addition, because in SHR removal of the endothelium
resulted in a greater attenuation of the myogenic tone
than administration of indomethacin or SQ 29,548
(bottom panels of Fig 2 versus Figs 3 or 4), we surmise
that a nonprostanoid factor, synthesized in arteriolar
endothelial cells, also contributes to the enhanced pres-
sure-induced constriction of these arterioles.
It is likely that changes similar to those described
here occur in arterioles of other types of skeletal
muscle. This could then lead to significant increases in
peripheral resistance and blood pressure and at the
same time would place greater demand on shear stress-
dependent21-37 and metabolic44 mechanisms known to
have the ability to oppose the development of a positive
feedback cycle of increased myogenic constriction.
In conclusion, the present study is the first demon-
stration of an endothelium-dependent, enhanced pres-
sure-induced constriction of arterioles of genetically
hypertensive rats. This augmented constriction is in part
due to an enhanced synthesis of PGH2. The present
findings suggest an important role for the altered vaso-
active function of endothelium of skeletal muscle arte-
rioles in the pathogenesis of hypertension.
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